Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Fort Dodge Animal Health assets ‘may be acquired by Boehringer Ingelheim’

Fort Dodge Animal Health assets ‘may be acquired by Boehringer Ingelheim’

6th August 2009

Fort Dodge Animal Health is likely to have some of its assets purchased by Boehringer Ingelheim, it has been reported.

Citing “sources familiar with the situation”, Reuters said that the company is the “front-runner” to buy the assets that are being divested by Wyeth.

The news agency explained that Wyeth must eliminate part of its Fort Dodge livestock and veterinary animal health business in order to gain approval for its merger with Pfizer.

Reuters reported: “Wyeth is not selling its entire Fort Dodge business, just certain assets within the unit that are valued at roughly $400 million (235 million pounds) to $500 million, the sources said.”

The Fort Dodge Animal Health business makes a variety of different products, including ProHeart6, ProMeris and the Duramune range of vaccines.

At their annual meeting, the 2009 edition of which was held last month, Wyeth’s stockholders “overwhelmingly” approved the adoption of its merger agreement with Pfizer.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.